VEGF targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma

Combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer

Combination of pazopanib and paclitaxel safe in urothelial cancer

Tackling renal cancer with a combination of autologous immunotherapy and sunitinib

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction

mRCC: Real-world experience: achieving efficacy beyond clinical trials

mRCC: Are we doing all we can to manage adverse events?

mRCC: Understanding the patient's perspective

mRCC: Closing remarks

ecancermedicalscience Special Issue: Fertility sparing

Advances in haemato-oncology: Expert panel discussion

Optimizing survival in advanced prostate cancer: Tailoring mCRPC therapies to optimise survival